AJR Am J Roentgenol

1. CHARALEL RA, Mushlin AI, Zheng X, Mao J, et al
   Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison.
   AJR Am J Roentgenol. 2024 Jun 20. doi: 10.2214/AJR.24.31272.
   

   >> Share

   
   

   
   Am J Pathol

2. LAURENT-BELLUE A, Sadraoui A, Claude L, Calderaro J, et al
   Deep learning classification and quantification of pejorative and non-pejorative architectures in resected hepatocellular carcinoma from digital histopathological images.
   Am J Pathol. 2024 Jun 13:S0002-9440(24)00206.
   

   >> Share

   
   

   
   Ann Intern Med

3. MIRONOVA M, Sherker AH
   In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.
   Ann Intern Med. 2024;177:JC63.
   

   >> Share

   
   
4. LAKE JE, Kitch DW, Kantor A, Muthupillai R, et al
   The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
   Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3354.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

5. ERITEN B, Caglayan C, Gur C, Kucukler S, et al
   Hepatoprotective effects of zingerone on sodium arsenite-induced hepatotoxicity in rats: Modulating the levels of caspase-3/Bax/Bcl-2, NLRP3/NF-kappaB/TNF-alpha and ATF6/IRE1/PERK/GRP78 signaling pathways.
   Biochem Biophys Res Commun. 2024;725:150258.
   

   >> Share

   
   

   
   BMC Cancer

6. DU CF, Gao ZY, Xu ZD, Fang ZK, et al
   Prognostic value of the Naples prognostic score in patients with intrahepatic cholangiocarcinoma after hepatectomy.
   BMC Cancer. 2024;24:727.
   

   >> Share

   
   

   
   BMC Gastroenterol

7. ZHANG Y, Yu W, Zhou S, Xiao J, et al
   Finding key genes (UBE2T, KIF4A, CDCA3, and CDCA5) co-expressed in hepatitis, cirrhosis and hepatocellular carcinoma based on multiple bioinformatics techniques.
   BMC Gastroenterol. 2024;24:205.
   

   >> Share

   
   

   
   Cancer Res

8. SHIRANI M, Levin S, Shebl B, Requena D, et al
   Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1.
   Cancer Res. 2024 Jun 18. doi: 10.1158/0008-5472.CAN-23-4110.
   

   >> Share

   
   
9. LI L, Xie D, Yu S, Ma M, et al
   WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma.
   Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-23-1167.
   

   >> Share

   
   

   
   Dig Dis Sci

10. YANG JO, Chittajallu P, Benhammou JN, Patel A, et al
    Validation of a Machine Learning Algorithm, EVendo, for Predicting Esophageal Varices in Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08449.
    

    >> Share

    
    

    
    Eur Radiol

11. FURUMAYA A, Willemssen FEJA, Miclea RL, Haring MPD, et al
    Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2024 Jun 20. doi: 10.1007/s00330-024-10829.
    

    >> Share

    
    
12. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Correction: Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2024 Jun 18. doi: 10.1007/s00330-024-10745.
    

    >> Share

    
    

    
    Hepatology

13. ABERG F, Asteljoki J, Mannisto V, Luukkonen PK, et al
    Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population.
    Hepatology. 2024;80:163-172.
    

    >> Share

    
    
14. FLORIS A, Chandla S, Lim Y, Barbier-Torres L, et al
    Sumoylation of methionine adenosyltransferase alpha 1 promotes mitochondrial dysfunction in alcohol-associated liver disease.
    Hepatology. 2024;80:102-118.
    

    >> Share

    
    
15. LOPEZ-PASCUAL A
    Navigating liver disease complexity: Innovations in in vitro modeling and precision medicine.
    Hepatology. 2024;80:20-23.
    

    >> Share

    
    
16. SCHONFELD M, O'Neil M, Weinman SA, Tikhanovich I, et al
    Alcohol-induced epigenetic changes prevent fibrosis resolution after alcohol cessation in miceresolution.
    Hepatology. 2024;80:119-135.
    

    >> Share

    
    
17. TONG Y, Wang F, Li S, Guo W, et al
    Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors.
    Hepatology. 2024;80:38-54.
    

    >> Share

    
    
18. SINGAL AK, Shah VH, Malhi H
    Emerging targets for therapy in ALD: Lessons from NASH.
    Hepatology. 2024;80:223-237.
    

    >> Share

    
    
19. LI J, Ma X, Xuan Q, Li Q, et al
    Modulation of monocyte activity by hepatocellular MicroRNA delivery via hepatitis B virus surface antigen particles: Implications for pathobiology of chronic hepatitis B.
    Hepatology. 2024 Jun 20. doi: 10.1097/HEP.0000000000000972.
    

    >> Share

    
    
20. YANG M, Song X, Zhang F, Li M, et al
    Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse.
    Hepatology. 2024 Jun 20. doi: 10.1097/HEP.0000000000000979.
    

    >> Share

    
    
21. LIU Q, Zhang X, Qi J, Tian X, et al
    Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for hepatocellular carcinoma.
    Hepatology. 2024 Jun 19. doi: 10.1097/HEP.0000000000000962.
    

    >> Share

    
    
22. 
    Erratum: c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
    Hepatology. 2024;80:E21.
    

    >> Share

    
    
23. 
    Process Measures to Improve Outcomes During Peri-Procedure Management of Coagulopathy in Cirrhosis.
    Hepatology. 2024 Jun 17. doi: 10.1097/HEP.0000000000000964.
    

    >> Share

    
    
24. HUANG L, Zou L
    Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
    Hepatology. 2024 Jun 17. doi: 10.1097/HEP.0000000000000974.
    

    >> Share

    
    
25. 
    Erratum: A prognostic strategy based on stage of cirrhosis and HVPG to improve risk stratification after variceal bleeding.
    Hepatology. 2024;80:E23.
    

    >> Share

    
    
26. 
    Hepatology Highlights.
    Hepatology. 2024;80:1-2.
    

    >> Share

    
    
27. LAINE L, Barkun AN, Leontiadis GI
    Letter to the Editor: Endoscopy for potential variceal bleeding within 12 hours-Not so fast!
    Hepatology. 2024;80:E15-E16.
    

    >> Share

    
    
28. KRAWCZYK M, Lammert F
    Letter to the Editor: NAFLD vs. MASLD-There ain't no such thing as a free lunch.
    Hepatology. 2024;80:E11-E12.
    

    >> Share

    
    
29. RINELLA ME, Lazarus JV, Newsome PN
    Reply: NAFLD vs. MASLD-There ain't no such thing as a free lunch.
    Hepatology. 2024;80:E13-E14.
    

    >> Share

    
    
30. MA J, Liangpunsakul S
    Solving the puzzle of fibrosis resolution in alcohol-associated liver disease: An insight from KDM5 demethylases and LXR activation.
    Hepatology. 2024;80:14-17.
    

    >> Share

    
    
31. DAVENPORT M
    Serum matrix metalloproteinase-7 (MMP-7): As good as it gets?
    Hepatology. 2024;80:18-19.
    

    >> Share

    
    
32. WOLTERS F, Oude Elferink RPJ, Beuers U
    PPARalpha, PPARdelta, or both-that is the question!
    Hepatology. 2024;80:8-10.
    

    >> Share

    
    
33. DONGELMANS E, Erler N, Adam R, Nadalin S, et al
    Recent outcomes of liver transplantation for Budd Chiari Syndrome - a study of the European Liver Transplant Registry (ELTR) and affiliated centers.
    Hepatology. 2024 Feb 15. doi: 10.1097/HEP.0000000000000778.
    

    >> Share

    
    
34. KOSHIOL J, Krawczyk M
    enHanCCing knowledge of genetic factors in primary liver tumor.
    Hepatology. 2024;80:11-13.
    

    >> Share

    
    
35. NEIL DAH, Smith ML, Minervini M, Demetris AJ, et al
    Reply: Additional viewpoints from transplant surgeons on Banff consensus recommendations for the assessment of steatotic donor livers.
    Hepatology. 2024;80:E6-E7.
    

    >> Share

    
    
36. CAO H, Gu J
    Letter to the Editor: Additional viewpoints from transplant surgeons on Banff consensus recommendations for the assessment of steatotic donor livers.
    Hepatology. 2024;80:E4-E5.
    

    >> Share

    
    
37. KREMER AE, Mayo MJ, Hirschfield GM, Levy C, et al
    Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis.
    Hepatology. 2023 Dec 20. doi: 10.1097/HEP.0000000000000728.
    

    >> Share

    
    

    
    Int J Cancer

38. BUI TT, Park E, Kang HY, Oh JK, et al
    Combined effects of smoking and alcohol consumption on the risk of liver cancer according to metabolic syndrome: A nested case-control study in South Korea.
    Int J Cancer. 2024;155:654-665.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

39. SOGABE M, Okahisa T, Kagawa M, Sei M, et al
    Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
    J Gastroenterol Hepatol. 2024 Feb 29. doi: 10.1111/jgh.16530.
    

    >> Share

    
    
40. LEE KJ, Moon JS, Lim JG, Huh H, et al
    PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children.
    J Gastroenterol Hepatol. 2024;39:1172-1182.
    

    >> Share

    
    
41. MAUNG ST, Tanpowpong N, Satja M, Treeprasertsuk S, et al
    MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2024 Jun 20. doi: 10.1111/jgh.16643.
    

    >> Share

    
    
42. MALIK S, Tenorio BG, Moond V, Dahiya DS, et al
    Systematic review of machine learning models in predicting the risk of bleed/grade of esophageal varices in patients with liver cirrhosis: A comprehensive methodological analysis.
    J Gastroenterol Hepatol. 2024 Jun 17. doi: 10.1111/jgh.16645.
    

    >> Share

    
    

    
    Transplant Proc

43. JABIRY-ZIENIEWICZ Z, Stelmach DA, Jasak K, Knap-Wielgus W, et al
    Pregnancy in Liver and Kidney Female Recipient: A Case Report.
    Transplant Proc. 2024;56:998-999.
    

    >> Share

    
    
44. JABIRY-ZIENIEWICZ Z, Stelmach DA, Jasak K, Knap-Wielgus W, et al
    Pregnancies in Women After Liver Transplant due to Wilson's Disease-Case Series.
    Transplant Proc. 2024 May 9:S0041-1345(24)00249.
    

    >> Share

    
    
45. CZARNECKA K, Czarnecka P, Tronina O, Baczkowska T, et al
    MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients.
    Transplant Proc. 2024;56:822-831.
    

    >> Share

    
    
46. YOU MW, Chuang SC, Liang HR, Chuang SH, et al
    Tacrolimus-Induced Hepatic Vein Occlusive Disease After Deceased Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2024 Jun 17:S0041-1345(24)00276.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share